Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review.

McNally, Christopher J; Ruddock, Mark W; Moore, Tara; McKenna, Declan J

McNally, Christopher J; Ruddock, Mark W; Moore, Tara; McKenna, Declan J.

Afiliación

McNally CJ; Randox Laboratories Ltd, Crumlin, Co. Antrim BT29 4QY, Northern Ireland.
Ruddock MW; Biomedical Sciences Research Institute, Ulster University, Coleraine BT52 1SA, Northern Ireland.
Moore T; Randox Laboratories Ltd, Crumlin, Co. Antrim BT29 4QY, Northern Ireland.
McKenna DJ; Biomedical Sciences Research Institute, Ulster University, Coleraine BT52 1SA, Northern Ireland.

Cancer Manag Res ; 12: 5225-5241, 2020.

Article en En | MEDLINE | ID: mdl-32669872

Palabras clave

benign prostatic hyperplasia; biomarkers; differentiation; prostate cancer; transrectal ultrasound-guided biopsy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Manag Res Año: 2020 Tipo del documento: Article Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google